ssRNA Viruses

Supports healthy immune defenses and seasonal resilience.

A 60mL bottle lasts 3.6 months for an adult. $45 USD.

The ssRNA Viruses Tincture is a targeted botanical and micronutrient formulation designed to support innate and adaptive immune responses against single-stranded RNA viruses, such as members of the Flaviviridae, Coronaviridae, and Orthomyxoviridae families. This formulation combines phytoactive compounds with immunomodulatory, antiviral, and antioxidant properties in a high-grade ethanol base to enhance bioavailability and broad-spectrum efficacy.

Key Botanical Components and Mechanisms

Nymphaea caerulea (Blue Lotus)

Blue lotus contains aporphine alkaloids such as nuciferine, which exhibit neurocalming effects and mild MAO inhibition. These may aid in autonomic regulation during viral illness, particularly in reducing sympathetic overactivation linked to cytokine cascades.

Rosa canina (Rosehip)

Rich in vitamin C, polyphenols, and carotenoids, rosehip acts as a potent antioxidant and immune-supportive agent. Its flavonoids help stabilize mast cells and support mucosal defense barriers during acute viral infections.

Sun-grown Algae (likely Spirulina or Chlorella spp.)

Cyanobacteria and microalgae contain phycocyanins and polysaccharides shown to modulate interferon production, enhance natural killer (NK) cell activity, and suppress viral replication. Spirulina extracts have been noted for their effects against influenza and HIV in vitro.

Cinchona spp. (Cinchona Bark)

Source of quinine and related alkaloids with antiplasmodial and antiviral activity. Quinine may inhibit viral replication by interfering with endosomal acidification and enhancing zinc ionophore activity, augmenting intracellular zinc uptake.

Quercetin (Flavonol)

A well-studied flavonoid with antiviral, anti-inflammatory, and zinc ionophore properties. Quercetin inhibits viral entry and replication of various ssRNA viruses including coronaviruses and influenza. It also helps modulate cytokine production and oxidative stress.

Zinc (Elemental)

An essential trace mineral critical for antiviral immunity. Zinc inhibits RNA-dependent RNA polymerase (RdRp) in many ssRNA viruses, including SARS-CoV-2. It also supports thymic function, interferon production, and membrane stability during infection.

Solvent System

Non-GMO French Vodka (80 proof)

This ethanol base (40% v/v) ensures effective extraction of a wide range of active compounds, including both hydrophilic and lipophilic phytochemicals. The alcohol acts as both a preservative and a delivery enhancer, improving compound penetration across mucosal and cellular membranes.

Summary

The ssRNA Viruses Tincture offers a multifaceted approach to immune support during acute or seasonal viral threats. It combines botanical antivirals, antioxidants, and a mineral cofactor to interfere with viral replication, support immune cell function, and mitigate inflammatory cascades. Its constituents are supported by traditional ethnobotanical use and modern pharmacological research. When used as part of a broader protocol, this tincture may enhance host resilience against ssRNA viral pathogens.

What You Can Do To Support Your Body

Goal: Support immune health and natural mucosal defenses.

Diet:

  • Fruits: Citrus (orange, lemon, grapefruit), kiwi, pomegranate, blueberries, blackberries

  • Vegetables: Broccoli, kale, spinach, bell peppers, garlic, onions

  • Herbs/Spices: Ginger, turmeric, oregano, thyme

  • Fungi: Shiitake, maitake, reishi

  • Minerals: Zinc (pumpkin seeds, sesame, chickpeas), selenium (Brazil nuts, sunflower seeds)

  • Beverages: Green tea, hibiscus tea, elderberry infusion

Lifestyle: Midday outdoor time for vitamin D, 7–9 hours sleep, regular handwashing, moderate daily movement.

Why diet matters: Nutrients like zinc, selenium, and plant antioxidants help maintain healthy immune responses and mucosal integrity, complementing the tincture’s immune-supportive focus.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Warning for Statin Users

Important Clinical Advisory for ssRNA Viruses Tincture Users

Individuals currently prescribed pharmaceutical blood thinners, including statins or anticoagulants, must discontinue these agents gradually under the supervision of a qualified medical professional before initiating the ssRNA Viruses Tincture. A tapering period of approximately two weeks is generally advised to allow the cardiovascular and hepatic systems to adjust. During this transition, a suitable plant-based anticoagulant—such as Wild Pathimugham (Caesalpinia sappan- recommended dosage is 1000 mgs per day)—should be introduced to maintain hemodynamic balance and clotting modulation. Co-administration of the tincture with pharmaceutical blood thinners is contraindicated due to potential cumulative effects on platelet inhibition and hepatic metabolism.

Why Plant-Based Blood Thinners May Be a Better Alternative to Pharmaceuticals

Conventional pharmaceutical blood thinners, such as statins, warfarin, or newer anticoagulants (e.g. rivaroxaban), are effective in reducing clot risk and managing cardiovascular events. However, they often come with significant side effects including muscle pain, liver stress, memory issues, and increased bleeding risk. Additionally, statins may interfere with mitochondrial function, nutrient absorption (particularly CoQ10 and vitamin D), and may impair immune modulation.

In contrast, certain plant-based alternatives—such as wild Pathimugham (Caesalpinia sappan), turmeric (Curcuma longa), ginger, ginkgo biloba, and garlic—have demonstrated anticoagulant and antiplatelet effects in peer-reviewed studies, while also providing anti-inflammatory, antioxidant, and often immunomodulatory benefits. These botanicals tend to work via multi-targeted mechanisms, modulating prostaglandins, thromboxane, nitric oxide, and platelet aggregation without sharply tipping the body into pathological bleeding.

The gradual shift to plant-based blood-thinning strategies allows for synergistic support of vascular health, immune resilience, and systemic balance, especially for individuals pursuing a whole-food, plant-based lifestyle. These approaches are typically gentler on the liver, do not disrupt cellular energy production, and may better harmonize with herbal formulas such as the ssRNA Viruses Tincture, which relies on integrated, immuno-supportive botanicals.

Nonetheless, transitioning off pharmaceutical blood thinners should always be done gradually and under the supervision of a qualified health professional. Regular monitoring is essential to ensure safety during any transition.

References

Chan, E. (2001). Displacement of warfarin from albumin by ginkgo biloba extract. The Lancet, 355(9191), 564–565.

Chen, Y., Fu, L., Han, Y., et al. (2022). Caesalpinia sappan and its bioactive components: A review on pharmacological properties and mechanisms of action. Frontiers in Pharmacology, 13, 905280.

Ekor, M. (2014). The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Frontiers in Pharmacology, 4, 177.

Li, Y., Wang, Y., Zhang, H., et al. (2018). The role of turmeric and its active compound curcumin in disease prevention and treatment. Nutrients, 10(11), 1553.

Mahady, G.B. (2001). Garlic: A review of its therapeutic effects and indicated interactions. American Journal of Health-System Pharmacy, 58(5), 450–456.

Srivastava, K.C. (1989). Antiplatelet principles from a food spice clove (Syzygium aromaticum L). Prostaglandins, Leukotrienes and Essential Fatty Acids, 38(3), 215–217.

Wójcikowski, K., Johnson, D.W., & Gobe, G. (2006). Medicinal herbal extracts—renal friend or foe? Part one: The toxicities of medicinal herbs. Nephrology, 11(3), 177–182.

Appendix: List of ssRNA Viruses

  • Coronaviridae: SARS-CoV, MERS-CoV, SARS-CoV-2

  • Flaviviridae: Dengue virus, Zika virus, West Nile virus, Yellow fever virus, Hepatitis C virus

  • Orthomyxoviridae: Influenza A, B, and C viruses

  • Paramyxoviridae: Measles virus, Mumps virus, Respiratory syncytial virus (RSV), Human parainfluenza viruses

  • Picornaviridae: Rhinoviruses, Poliovirus, Enteroviruses (e.g., EV-D68), Hepatitis A virus

  • Togaviridae: Chikungunya virus, Rubella virus, Eastern/Western/Venezuelan equine encephalitis viruses

  • Filoviridae: Ebola virus, Marburg virus

  • Arenaviridae: Lassa virus, Junín virus, Machupo virus

  • Rhabdoviridae: Rabies virus, Vesicular stomatitis virus

  • Caliciviridae: Norovirus, Sapovirus

  • Retroviridae: Human immunodeficiency virus (HIV-1 and HIV-2), Human T-lymphotropic virus (HTLV)

  • Bornaviridae: Borna disease virus